Well done Tyler80, you managed to get the info down in clear laymans terms, not an easy task. I've been a shareholder for about 2 years since I first heard the Novogen story and what they are trying to do but I have the advantage of having spent 4 years doing cancer research 20 years ago in the UK, I've been out of it for a long time but can still follow the jargon. As you said several platforms, not just one drug. MC does not seem to be factoring this in.
Add to My Watchlist
What is My Watchlist?